ArticleFrontiers in immunology2024

Poor prognostic factors for relapse of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies after combination therapy.

Shogo Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.